Medicine & Life Sciences
Tenofovir
100%
HIV
95%
Pre-Exposure Prophylaxis
82%
Pharmacokinetics
56%
HIV-1
41%
Dapivirine
36%
Emtricitabine
32%
Gels
28%
GSK1265744
24%
Safety
22%
Anti-Infective Agents
20%
HIV Infections
19%
Pharmaceutical Preparations
18%
tenofovir diphosphate
18%
Placebos
18%
Maraviroc
18%
Female Contraceptive Devices
16%
Foams and Jellies Vaginal Creams
12%
Clinical Trials
10%
Sexual and Gender Minorities
10%
Healthy Volunteers
9%
Virus Diseases
9%
Enema
8%
Critical Illness
8%
Therapeutic Irrigation
8%
efavirenz
8%
Fluconazole
8%
Infections
7%
Randomized Controlled Trials
7%
Helper-Inducer T-Lymphocytes
6%
Pregnancy
6%
Fumarates
6%
Blood Cells
6%
Uganda
6%
Male Genitalia
6%
Confidence Intervals
6%
Ritonavir
6%
Heterosexuality
6%
Injections
6%
N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
6%
GS-7340
5%
T-Lymphocytes
5%
Population
5%
Candida
5%
Acquired Immunodeficiency Syndrome
5%
Colon
5%